791 related articles for article (PubMed ID: 29850629)
1. Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease.
Gelders G; Baekelandt V; Van der Perren A
J Immunol Res; 2018; 2018():4784268. PubMed ID: 29850629
[TBL] [Abstract][Full Text] [Related]
2. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.
Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.
Ghosh A; Tyson T; George S; Hildebrandt EN; Steiner JA; Madaj Z; Schulz E; Machiela E; McDonald WG; Escobar Galvis ML; Kordower JH; Van Raamsdonk JM; Colca JR; Brundin P
Sci Transl Med; 2016 Dec; 8(368):368ra174. PubMed ID: 27928028
[TBL] [Abstract][Full Text] [Related]
4. Roles for the adaptive immune system in Parkinson's and Alzheimer's diseases.
Lindestam Arlehamn CS; Garretti F; Sulzer D; Sette A
Curr Opin Immunol; 2019 Aug; 59():115-120. PubMed ID: 31430650
[TBL] [Abstract][Full Text] [Related]
5. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and Parkinson's disease.
Wersinger C; Sidhu A
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):221-42. PubMed ID: 14561187
[TBL] [Abstract][Full Text] [Related]
7. Role of neurotoxicants and traumatic brain injury in α-synuclein protein misfolding and aggregation.
Rokad D; Ghaisas S; Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Brain Res Bull; 2017 Jul; 133():60-70. PubMed ID: 27993598
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.
Chistiakov DA; Chistiakov AA
Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.
Rocha EM; De Miranda B; Sanders LH
Neurobiol Dis; 2018 Jan; 109(Pt B):249-257. PubMed ID: 28400134
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
11. Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease.
Hirsch EC; Standaert DG
Mov Disord; 2021 Jan; 36(1):16-24. PubMed ID: 32357266
[TBL] [Abstract][Full Text] [Related]
12. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
[TBL] [Abstract][Full Text] [Related]
14. The role of innate immunity and inflammation in Parkinson´s disease.
Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.
Lastres-Becker I; Ulusoy A; Innamorato NG; Sahin G; Rábano A; Kirik D; Cuadrado A
Hum Mol Genet; 2012 Jul; 21(14):3173-92. PubMed ID: 22513881
[TBL] [Abstract][Full Text] [Related]
16. Correlation between protective immunity to α-synuclein aggregates, oxidative stress and inflammation.
Gruden MA; Yanamandra K; Kucheryanu VG; Bocharova OR; Sherstnev VV; Morozova-Roche LA; Sewell RD
Neuroimmunomodulation; 2012; 19(6):334-42. PubMed ID: 22986484
[TBL] [Abstract][Full Text] [Related]
17. Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson's Disease.
Hatton SL; Pandey MK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163013
[TBL] [Abstract][Full Text] [Related]
18. Updates on immunity and inflammation in Parkinson disease pathology.
Joshi N; Singh S
J Neurosci Res; 2018 Mar; 96(3):379-390. PubMed ID: 29072332
[TBL] [Abstract][Full Text] [Related]
19. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
Sommer A; Winner B; Prots I
Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
Garretti F; Agalliu D; Lindestam Arlehamn CS; Sette A; Sulzer D
Front Immunol; 2019; 10():303. PubMed ID: 30858851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
